Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
22.64
-0.15 (-0.66%)
Nov 20, 2024, 4:00 PM EST - Market closed
Nurix Therapeutics Market Cap
Nurix Therapeutics has a market cap or net worth of $1.60 billion as of November 21, 2024. Its market cap has increased by 459.93% in one year.
Market Cap
1.60B
Enterprise Value
1.17B
1-Year Change
459.93%
Ranking
Category
Stock Price
$22.64
Market Cap Chart
Since July 24, 2020, Nurix Therapeutics's market cap has increased from $704.09M to $1.60B, an increase of 127.77%. That is a compound annual growth rate of 20.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 1.61B | 222.51% |
| Dec 29, 2023 | 500.56M | -3.31% |
| Dec 30, 2022 | 517.68M | -59.92% |
| Dec 31, 2021 | 1.29B | 1.09% |
| Dec 31, 2020 | 1.28B | 81.45% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 10x Genomics | 1.59B |
| Certara | 1.58B |
| Neumora Therapeutics | 1.57B |
| Immunocore Holdings | 1.55B |
| Kiniksa Pharmaceuticals International, | 1.54B |
| Teladoc Health | 1.53B |
| Dynavax Technologies | 1.53B |
| Arvinas | 1.51B |